Shares of Avalon GloboCare Corp (NASDAQ:ALBT) are trading sharply higher Thursday morning after Benzinga exclusively reported that the company joined Advanced Micro Devices Inc’s (NASDAQ:AMD) AI Developer Program.
Here’s what investors need to know.
Avalon Quantum AI Joins AMD
In the release, the Freehold, N.J.-based company said its AI-focused subsidiary, Avalon Quantum AI LLC, has been accepted into the AMD AI Developer Program, giving it access to AMD Developer Cloud credits, development tools, training and community resources, plus high-performance computing powered by AMD Instinct accelerators and EPYC processors.
Avalon plans to leverage those resources to scale its automated commentary video engine, enterprise documentation tools and an AI-powered workflow automation platform.
Avalon Advances AI, KetoAir Strategy
Interim CEO and COO Meng Li said the program reinforces Avalon’s repositioning as a technology-focused AI company and positions AQAI as a core growth driver in automated media production and enterprise AI applications.
Avalon is also advancing KetoAir, a handheld breathalyzer designed for ketogenic health management that recently renewed its establishment registration with the U.S. Food and Drug Administration.
Avalon says the device, which connects to iOS and Android apps, is expected to enter broader business-to-business and direct-to-consumer marketing in the second quarter of 2026, with AQAI helping drive data-driven marketing and distribution.
ALBT Shares Surge Over 100% Thursday
ALBT Price Action: Avalon Globocare shares were up 96.42% at $1.00 at the time of publication on Thursday, according to Benzinga Pro data.
Image: Shutterstock
